36 filings
Page 2 of 2
8-K
t5m850t 317hp5zi
4 Aug 15
Vitae Pharmaceuticals Reports Second Quarter 2015 Operating and Financial Results
12:00am
8-K
7pwmhz
29 Jul 15
Vitae Pharmaceuticals Appoints Dr. John M. Leonard to Board of Directors
12:00am
8-K
2ofx ud3dcmsh7693llf
27 Jul 15
Vitae Pharmaceuticals and Boehringer Ingelheim to End Collaboration and License Agreement for BACE Inhibitors
12:00am
8-K
mu5 h7d4760yj6mwfgli
29 Jun 15
Other Events
12:00am
8-K
ebi5jn8i9rt x9lm
29 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
a6pgr5mtznixve4szk2h
12 May 15
Vitae Pharmaceuticals Reports First Quarter 2015 Operating and Financial Results
12:00am
8-K
jakb8 3f4cu6xjc
31 Mar 15
Vitae Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Operating and Financial Results
12:00am
8-K
3xd9 gjugdjnpgvy
20 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
nvfzfama8 sc
26 Feb 15
Other Events
12:00am
8-K
kw5ztaq3gnk8o
28 Jan 15
Other Events
12:00am
8-K
gx3ibttcg7ykdc91v
15 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
cs0wmvu3ma
23 Dec 14
Other Events
12:00am
8-K
397 9p7kq2jkjyzh
12 Nov 14
Vitae Pharmaceuticals Reports Third Quarter 2014 Operating and Financial Results
12:00am
8-K
8gb ijt2shlau4k1e
27 Oct 14
Vitae Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional Shares of Initial Public Offering
12:00am
8-K
t11c5jp12 05t
23 Oct 14
Positive Top-Line Results achieved from Two Phase 1 Clinical Trials of BACE Inhibitor BI1181181/VTP-37948 in Alzheimer’s Disease
12:00am
8-K
geioyl82vh9 dbe0tsj0
29 Sep 14
Vitae Pharmaceuticals Announces Closing of Initial Public Offering
12:00am